Abstract |
S 35171 is one of a family of compounds that have been designed to protect mitochondrial function. We tested the hypothesis that S 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats (SHRSPs), an animal model developing spontaneous brain damage preceded by proteinuria and systemic inflammation revealed by the urinary accumulation of acute-phase proteins (APPs) originating in the liver. Male SHRSPs fed a permissive diet received vehicle or S 35171 (10 mg/kg/day) started simultaneously with a high- sodium diet (group A) or after the establishment of proteinuria (group B). The drug delayed urinary APPs accumulation and the appearance of magnetic resonance imaging (MRI)-monitored brain lesions (after 62+/-3 days in group A, and 51+/-2 days in controls, P<0.01). The delay was more pronounced in group B as 30% of the animals survived the entire 90-day experimental period without brain abnormality. Proteomic analysis showed no significant alteration in the expression pattern of brain mitochondrial proteins, but the liver mitochondrial levels of carbamoylphosphate synthase I (CPS-I), an enzyme involved in urea metabolism) and the antioxidant peroxiredoxin-3 spot were affected by hypertension and S 35171. Stress reduces CPS-I and induces the peroxiredoxin-3 spot, whereas S 35171 brought about normal CPS-I expression and a 12-fold higher level of the peroxiredoxin-3 spot. As both enzymes are involved in maintaining mitochondrial functions, their increased expression after S 35171 treatment may be responsible for delaying the pathological condition that leads to the development of brain damage in SHRSPs.
|
Authors | Paolo Gelosa, Cristina Banfi, Maura Brioschi, Elena Nobili, Anita Gianella, Uliano Guerrini, Alice Pignieri, Elena Tremoli, Luigi Sironi |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 604
Issue 1-3
Pg. 117-24
(Feb 14 2009)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 19135993
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acute-Phase Proteins
- Antihypertensive Agents
- S 35171
- Sodium, Dietary
- Trimetazidine
|
Topics |
- Acute-Phase Proteins
(biosynthesis, urine)
- Animals
- Antihypertensive Agents
(administration & dosage, pharmacology, therapeutic use)
- Blood Pressure
(drug effects)
- Blotting, Western
- Electrophoresis, Gel, Two-Dimensional
- Hypertension
(complications, drug therapy, pathology)
- Liver
(drug effects, metabolism)
- Magnetic Resonance Imaging
- Male
- Mitochondria
(drug effects, enzymology, metabolism, physiology)
- Proteinuria
(prevention & control)
- Rats
- Rats, Inbred SHR
- Sodium, Dietary
(administration & dosage)
- Stroke
(etiology, pathology, prevention & control)
- Trimetazidine
(administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
|